Editorial: Role of complement activation in kidney diseases

Front Med (Lausanne). 2023 Oct 19:10:1297938. doi: 10.3389/fmed.2023.1297938. eCollection 2023.

Authors

Takashi Oda¹, Toshihiro Sawai²

Affiliations

¹ Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan.
² Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.

No abstract available

Keywords: alternative pathway; avacopan; classical pathway; complement activation; eculizumab; kidney diseases; lectin pathway.

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.